HALLE (SAALE), Germany: The use of medical implants can be hampered by chronic inflammatory reactions, which may result in failure of the device. Now, researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a new method of applying anti-inflammatory substances to implants in order to inhibit undesirable inflammatory reactions in the body.
DÜBENDORF, Switzerland: Researchers of the Swiss Federal Laboratories for Materials Science and Technology (Empa) and the Swiss Federal Institute of Technology in Lausanne (EPFL) have jointly developed a fully transparent surgical mask that is intended to replace the three-layer mask normally worn by medical staff. The mask was developed primarily with the aim of improving non-verbal communication between nursing staff and patients but could also be worn by dentists to protect against transmission of bacteria and viruses, such as SARS-CoV-2. The product is expected to be launched in early 2021.
DAVOS, Switzerland: An international cross-sectional survey has found that most surgeons believed that the supply of personal protective equipment (PPE) to front-line healthcare workers by hospitals in the first month of the SARS-CoV-2 outbreak was inadequate.
HALLE (SAALE), Germany: Pharmacists at Martin Luther University Halle-Wittenberg (MLU), in cooperation with neurosurgeons at university hospital Halle (Saale), have developed a new method that allows direct application of the drug nimodipine in the brain with fewer side effects. The drug may prevent nerve cells from dying after brain surgery.
LONDON, UK: Bariatric and metabolic surgery, used to treat Type 2 diabetes and obesity, has been suspended during the COVID-19 pandemic in order to free up inpatient capacity and reduce the risks of infection among patients and staff. However, in a recent paper, experts from the Diabetes Surgery Summit (DSS), an international consensus conference series, have warned that the backlog of operations could increase risks of morbidity and mortality for patients awaiting surgery.
In order to provide an alternative implant solution for those patients with poor medical preconditions, Prof. Nils-Claudius Gellrich, director of the clinic for oral and maxillofacial surgery at the Hannover Medical School in Germany, and Dr Björn Rahlf, senior physician for oral surgery at the same clinic, designed the IPS (individual patient solution) Implants Preprosthetic. In conversation with Dental Tribune International, Gellrich and Rahlf spoke about the patients for whom it is suitable and how they developed this individual implant.
LEEDS, UK: In a recently published consensus statement, leading cancer experts have discussed radiotherapy treatment options for rectal cancer during the COVID-19-pandemic. In their paper, they recommended a one-week course of radiotherapy and to delay surgery for patients with bowel cancer.
LONDON, UK: Since the outbreak of SARS-CoV-2 there have been speculations that the intake of non-steroidal anti-inflammatory drugs (NSAIDs) could worsen the course of COVID-19. However, a recent study conducted by researchers from King’s College London and Guy’s and St. Thomas NHS Foundation Trust (GSTT), has found that there is neither evidence for nor against the use of NSAIDs such as ibuprofen for patients infected with COVID-19.
GOTHENBURG, Sweden: A research team from Sahlgrenska University Hospital at the University of Gothenburg has, for the first time, transplanted a uterus from a deceased donor. The operation proceeded without complications and the recipient is doing well. The researchers plan to carry out another five transplants of a deceased donor’s uterus in the course of 2020 and 2021.
BERN/ZURICH, Switzerland: There is increasing evidence that health behaviour and disease manifestation differ substantially between women and men. The universities of Bern and Zurich are now offering the first continuing education program in sex- and gender-specific medicine in Switzerland. The program will start in May and aims to stimulate the implementation of sex- and gender-specific medicine in research and clinical practice. The course is unique in this form in Europe.
TUTTLINGEN, Germany/ZURICH, Switzerland: KARL STORZ, a leading endoscopy manufacturer, and VirtaMed, a world leader in medical training simulation, have introduced a novel mixed reality simulator bringing innovation to laparoscopic skills training.
GENEVA, Switzerland: Approximately one in 25 individuals—representing between 187 million and 280 million cases globally—undergoes major surgery annually for the treatment of disease, injury or illness. Although medical treatments are constantly evolving, postsurgical complications continue to represent a substantial burden for both patients and healthcare systems. A recent review investigated the correlation between smoking and postsurgical risks and found that tobacco smokers are at significantly higher risk than non-smokers for postsurgical complications.
AUGSBURG, Germany: Physicists at the University of Augsburg, in cooperation with scientists from the University Medical Center Hamburg-Eppendorf and the Technical University of Munich, have developed a new coating that releases antimicrobial ions. In the future, it could help prevent complications during the healing of endoprostheses.
ZURICH, Switzerland: Researchers from the University Hospital Zurich (UHZ), Swiss Federal Institute of Technology in Zurich (ETH Zurich), Wyss Zurich and the University of Zurich (UZH) have developed a machine that repairs injured human livers and keeps them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation.
BASEL, Switzerland/HELSINKI, Finland: Haematopoietic stem cell transplantation is used to treat cancers and severe blood and autoimmune diseases. Owing to slow immune system recovery after the transplantation, patients have a heightened risk of infection. However, a recent study has reported that the presence of acute or chronic oral foci of infection before the transplantation does not affect the patient’s survival rate within six months of the procedure.
OSLO, Norway: Aortic stenosis is caused by aortic valve calcification, a challenging condition for the health service and for affected patients. The only treatment currently available is surgery, which holds risks and challenges. Therefore, researchers from the University of Oslo have investigated possible pharmacological therapy options in order to develop a non-surgical treatment.
CLEVELAND, U.S.: Cleveland Clinic has become the first hospital in the world to successfully perform a robotic single-port kidney transplant, which enables all surgical instruments and the donor kidney to be placed through one small abdominal incision.
LEICESTER, UK: While short-term results of surgery are excellent, many patients fail to obtain long-term benefits the reasons for which remain unclear. Academics from the University of Leicester are researching why this is and have defined the top priorities for UK cardiac surgery research.